Biotech Entrepreneur and co-founder and Chief Executive Officer at Rejuveron Life Sciences
Matthias has more than 20 years pharma / biotech experience and is the co-founder of Endogena Therapeutics. As former global head of research and technology partnering at Roche, Matthias set up and managed > 50 collaborations and acquisitions for novel drug modalities, drug discovery technologies and enabling technologies. He also established Roche’s stem cell research programme. An entrepreneur at heart, Matthias set up a pioneering orphan G-protein coupled receptor (GPCR) drug discovery company, which resulted in a successful acquisition. He gained financial experience as an investment banking analyst at Kepler Equities.
Visit website: https://rejuveron.com/en/who-we-are#people
See also: Rejuveron - Company that develops and invests in drugs and technologies which prolong human lifespan.
Matthias Steger is also referenced in the following:
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
Symposium about healthy living organized by Rejuveron (FREE)